Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings in Brief: Voxel

This article was originally published in The Gray Sheet

Executive Summary

Voxel: Files registration statement with SEC for a proposed 2.3 mil. share public offering, net proceeds from which will be used to support "completion of development of the Digital Holography System, for expansion of marketing and sales activities for the system through 1997, to finance revenue growth and the accompanying increases in inventory and accounts receivable, and for general corporate purposes and working capital," the firm says. Laguna Hills, California-based Voxel received 510(k) clearance from FDA last fall for its Digital Holography system, which includes a camera, a light box, and film that interface with CT and MR scanners "to produce `three dimensional x-rays,'" the firm says. Cruttenden Roth Incorporated will underwrite the offering...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006300

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel